Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions

Key facts

Sponsor

AI Labs Group S.L

Principal Investigator

Miguel Sánchez-Viera, PhD

IDEI Hospital

Enrollment

150 enrolled

Eligibility

16 years · All sexes

Timeline

2024 – 2024

Study locations (1)

• IDEI Hospital, Madrid, Spain

Collaborators

Instituto de Dermatología Integral (IDEI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07487948
  Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris
  Icahn School of Medicine at Mount Sinai
• RECRUITINGPHASE2NCT07533006
  A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
  Eli Lilly and Company
• ENROLLING BY INVITATIONNCT07499713
  Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata
  Istanbul Training and Research Hospital
• RECRUITINGPHASE3NCT07435012
  Androgenic Alopecia TH07 Clinical Trial
  Triple Hair Inc
• RECRUITINGNANCT07422376
  Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands Region
  Charles Mays
• RECRUITINGNCT07226531
  Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US
  Pfizer
• RECRUITINGNANCT07563036
  JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil
  Kasr El Aini Hospital
• RECRUITINGPHASE2NCT07370519
  Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia
  Shenzhen People's Hospital

See all trials for Alopecia →